MedTrace Logo

Cardiac Substructure Radiation Dose and Early Clinical Monitoring of Stage N2-3 Non-Small Cell Lung Cancer

NCT05252065 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-02-23

No results posted yet for this study

Summary

Calculating which cardiac substructure accepting with the highest radiation dose by conventional radiotherapy, then to investigate the relationship between the changes of global longitudinal strain or cardiac magnetic resonance imaging and cardiac biomarkers and the certain cardiac substructure for stage N2-3 non-small cell lung cancer

Conditions

Interventions

OTHER

Cardiac biomarkers, Echocardiography,Cardiac magnetic resonance imaging

Troponin I, troponin T, hypersensitive troponin, brain natriuretic peptide and NT-proBNP are detected for cardiac biomarkers;echocardiography and cardiac magnetic resonance imaging are used to measure the functions of heart and vessels.

Sponsors & Collaborators

  • Guizhou Medical University

    lead OTHER

Principal Investigators

  • Bing Lu · Department of thoracic oncology, Affiliated Cancer Hospital of Guizhou Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2022-12-30
Completion
2022-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05252065 on ClinicalTrials.gov